U.S. commits $1.2 billion to possible British COVID vaccine

U.S. commits $1.2 billion to possible British COVID vaccine

Reuters

Published

The United States will pump up to $1.2 billion into developing AstraZeneca's potential COVID-19 vaccine and said on Thursday it would order 300 million doses, as the White House seeks solutions to the coronavirus pandemic.

Full Article